Medicine Description trajenta 5 mg
trajenta 5 mg tablets is a medication that contains linagliptin, which functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor. This class of drugs works by preventing the breakdown of incretin hormones, which are released by the intestines in response to food intake. Incretins play a crucial role in glucose metabolism by stimulating insulin secretion from the pancreas and inhibiting glucagon release from the liver. By prolonging the action of incretins, linagliptin enhances insulin production when glucose levels are elevated and decreases glucose production in the liver, effectively helping to regulate blood sugar levels in individuals with type 2 diabetes.
Indications and Uses of trajenta 5 mg tablets
- Management of type 2 diabetes mellitus in conjunction with diet and exercise
- Used alone or in combination with other antidiabetic medications
Side Effects of trajenta 5 mg tablets
- Hypoglycemia (especially when used with other antidiabetic agents)
- Nausea
- Diarrhea
- Headache
- Upper respiratory tract infections
- Pancreatitis (in rare cases)
Storage and Handling
Store Trajenta tablets at room temperature, away from moisture and heat. Keep out of reach of children. Ensure the original packaging is intact until use.
Patient Advice and Precautions
Monitor blood sugar levels regularly as advised by your healthcare provider. Be aware of signs of hypoglycemia, especially if combining with other diabetes medications. Inform your doctor about any other medications you are taking to avoid potential interactions. Maintain a healthy diet and exercise routine to optimize diabetes management.